Global Tumor Ablation Market 2023-2029

Tumor ablation is a minimally invasive medical procedure that is used to destroy cancer cells within tumors. This procedure involves the use of heat, cold, or chemicals to destroy cancer cells within tumors, which may be primary or metastatic. Tumor ablation is considered a minimally invasive procedure because it does not require surgery to access tumors. Instead, a small incision is made through the skin, and a special probe is inserted into the tumor to deliver the heat, cold, or chemicals used for ablation. Tumor ablation can be used in combination with other cancer treatments, such as chemotherapy or radiation therapy, to increase the effectiveness of cancer treatment. According to the latest estimates, the global tumor ablation market size is expected to increase from USD 919.0 million in 2022 to USD 1,939.5 million by 2029, garnering a CAGR of 11.26% over the evaluated period.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global tumor ablation market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, treatment, application, end user, and region. The global market for tumor ablation can be segmented by technology: radiofrequency, microwave, irreversible electroporation, cryoablation, other. The radiofrequency segment was the largest contributor to the global tumor ablation market in 2022. Tumor ablation market is further segmented by treatment: surgical ablation, percutaneous ablation, laparoscopic ablation. According to the research, the surgical ablation segment had the largest share in the global tumor ablation market. Based on application, the tumor ablation market is segmented into: lung cancer, kidney cancer, liver cancer, others. The lung cancer segment held the largest revenue share in 2022. On the basis of end user, the tumor ablation market also can be divided into: hospitals and clinics, specialty centers, others. Globally, the hospitals and clinics segment made up the largest share of the tumor ablation market. Tumor ablation market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By technology: radiofrequency, microwave, irreversible electroporation, cryoablation, other
By treatment: surgical ablation, percutaneous ablation, laparoscopic ablation
By application: lung cancer, kidney cancer, liver cancer, others
By end user: hospitals and clinics, specialty centers, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, SonaCare Medical, LLC, EDAP TMS SA, AngioDynamics, Inc., HealthTronics, Inc., Misonix, Inc., Biotronik, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global tumor ablation market.
To classify and forecast the global tumor ablation market based on technology, treatment, application, end user, region.
To identify drivers and challenges for the global tumor ablation market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global tumor ablation market.
To identify and analyze the profile of leading players operating in the global tumor ablation market.

Why Choose This Report
Gain a reliable outlook of the global tumor ablation market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY TECHNOLOGY
Radiofrequency
Microwave
Irreversible electroporation
Cryoablation
Other
PART 6. MARKET BREAKDOWN BY TREATMENT
Surgical ablation
Percutaneous ablation
Laparoscopic ablation
PART 7. MARKET BREAKDOWN BY APPLICATION
Lung cancer
Kidney cancer
Liver cancer
Others
PART 8. MARKET BREAKDOWN BY END USER
Hospitals and clinics
Specialty centers
Others
PART 9. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 10. KEY COMPANIES
Johnson & Johnson
Medtronic plc
Boston Scientific Corporation
SonaCare Medical, LLC
EDAP TMS SA
AngioDynamics, Inc.
HealthTronics, Inc.
Misonix, Inc.
Biotronik, Inc.
DISCLAIMER

Global Hematology Flow Cytometry Database

2024 Global Hematology and Flow Cytometry Database: US, Europe, Japan--Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts This database from provides the 2023 supplier shares, the 2023-2028

USD 14500 View Report

Global Hematology Market Shares Competitive Analysis

2023 Global Hematology Market Shares in the US, Europe, and Japan--Competitive Analysis of Leading and Emerging Market Players This new report provides hematology market shares for France, Germany, Italy, Japan,

USD 1450 View Report

Global Tumor Markers Diagnostic Testing Market Assessment

LeadingMarketResearch.coms new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S.,

USD  18500 View Report

Global Tumor Markers Testing Market High Growth Opportunities for Cancer Diagnostic Tests and Analyzers 

New report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years.The report is available by section, and can

USD 19500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available